Clinical Trial Update: A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer [NA]

View source ↗

Summary

A pan-Canadian investigator-initiated clinical trial evaluating focal irreversible electroporation for intermediate-risk prostate cancer is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | NA | Status: RECRUITING